Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

inflammatory diseases

This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.

J&J files new Darzalex formulation in US and Europe

J&J files new Darzalex formulation in US and Europe

Sanofi has also said it thinks that isatuximab could be safer to use in patients with inflammatory diseases like asthma, as unlike Darzalex it is not associated with complement activation, and

Latest news

  • FDA verdict on Sanofi’s Darzalex rival is due in April 2020 FDA verdict on Sanofi’s Darzalex rival is due in April 2020

    The French drugmaker also thinks that isatuximab could be safer to use in patients with inflammatory diseases like asthma, as unlike Darzalex, it is not associated with complement activation, and will

  • Tiziana joins type 1 diabetes prevention field Tiziana joins type 1 diabetes prevention field

    The phase 2 compound of foralumab has potential applications in a variety of autoimmune and inflammatory diseases, which Tiziana has based on promising animal studies. ... These show that when nasally or orally introduced, the drug has the potential for

  • Syncona start-up Quell Therapeutics appoints chief exec Syncona start-up Quell Therapeutics appoints chief exec

    The company says it will target a range of conditions including solid organ transplant rejection, autoimmune and inflammatory diseases. ... Numerous other companies are investigating the potential of Tregs, including Genentech, which recently signed a

  • Amgen buys Danish partner Nuevolution for $167m Amgen buys Danish partner Nuevolution for $167m

    Amgen also takes control of an early-stage internal pipeline which also includes a RORγt Inhibitor for cancer and other indications, as well as BET bromodomain inhibitors for inflammatory diseases and

  • Syncona launches another cell therapy company, Treg specialist Quell Syncona launches another cell therapy company, Treg specialist Quell

    The UK-based life sciences venture capital firm is launching Quell with the aim of developing Tregs therapies for solid organ transplant rejection, autoimmune and inflammatory diseases, with another £1m in ... such as type 1 diabetes, rheumatoid

More from news
Approximately 4 fully matching, plus 116 partially matching documents found.

Latest Intelligence

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing

  • ‘How is your day?’ ‘How is your day?’

    Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP

  • The tipping point The tipping point

    In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

  • Taking a lean and careful approach Taking a lean and careful approach

    Its fully human engineered CD3 antibody Foralumab has reached phase II with potential for a wide range of autoimmune and inflammatory diseases such as non-alcoholic steatohepatitis (NASH), primary biliary cholangitis, ... Database of diseases. The

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    It is a good fit strategically for us because it enriches our portfolio in the area of inflammatory and pain-related diseases with high unmet need. ... Pain has nervous and inflammatory components and we are interested in everything around the

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Infographic: Spondyloarthritis

    Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Quick links

Infographics

Multimedia